Surgery, Gastroenterology and Oncology
Vol. 20, No. 4, December 2015
Immunological and molecular mechanisms in NAFLD
Ionel Copaci, Laurenţiu Micu, Grethi Chiriac, Eugenia Mindrut, Gener Ismail, Luminiţa Leurzeanu
REVIEW, December 2015
Article DOI: 10.21614/jtmr-20-4-57
Chronic metabolic inflammation, maintained by numerous proinflammatory mediators, links the metabolic syndrome to NASH. Epigeal changes that accelerate the synthesis of proinflammatory mediators in response to nutritional factors and life style are not fully known.
Numerous proinflammatory transcription pathways have been described where nuclear factor kappa B plays a critical role in stimulating proinflammatory gene promoter region interdependent with epigenetic machinery. Of the many cytokines, adipokines, myokines involved in the evolution of NAFLD from simple steatosis to NASH and cirrhosis, the most important is the balance between proinflammatory cytokines TNFÎ+- and IL 6 on one hand and adiponectin on the other hand, these factors being produced by Kupffer cells, hepatic stellate cells and inflammatory hepatocytes.

Starting from the classical "two hit" theory of the pathogenesis of NAFLD, recent studies have revealed the important role of free cholesterol, diacylglycerols and ceramides in the induction of insulin resistance by stimulating sterol-element-binding protein 1c and thus stimulating de novo lipogenesis. The important roles of mitochondrial dysfunction, oxidative stress endoplasmic reticulum, inflammasomes, hepatocyte apoptosis and necrosis have also been highlighted.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2953


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.